FONT-SIZE Plus   Neg

Valeant Pharma, Actavis In Merger Talks : WSJ

Canadian drugmaker Valeant Pharmaceuticals International, Inc. (VRX,VRX.TO) is said to be in discussions to acquire rival Actavis Inc. (ACT) for over $13 billion, according to the Wall Street Journal.

While the companies were working towards an all-stock deal announcement, few Actavis' directors were against it around the middle of this week. But the executives on both sides are still working to resurrect the deal, the journal added.

In February, Valeant announced that it was in talks to make more acquisitions, and it remains open to discuss a potential "merger of equals". Actavis currently has a market value of nearly $13 billion.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Uber's self-driving technology start-up Otto has partnered with Anheuser-Busch InBev to complete the world's first shipment by a self-driving truck. Otto said in a blog post that the company and Anheuser-Busch delivered 51,744 cans of Budweiser beer from Fort Collins, through downtown Denver, to Colorado Springs. Netflix Inc. has lined up plenty of new, original Netflix shows and movies for November. The return of the highly anticipated "Gilmore Girls: A Year in the Life" and Leonardo DiCaprio-produced documentary "The Ivory Game," which is focused on ivory trafficking, are among the main highlights that will arrive on Netflix in November. General Motors will introduce upgraded OnStar Go in cars to connect and interact with favorite brands. The car-maker has partnered with IBM's Watson to improve its OnStar service and the two companies will share the revenue from the project.
comments powered by Disqus
Follow RTT